Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ASTH Astrana Health
- 37.630
- -0.110-0.29%
Close Dec 13 16:00 ET
- 37.630
- 0.0000.00%
Post 16:20 ET
1.85BMarket Cap28.95P/E (TTM)
37.920High37.260Low214.23KVolume37.570Open37.740Pre Close8.05MTurnover0.60%Turnover Ratio29.17P/E (Static)49.12MShares63.20052wk High2.62P/B1.34BFloat Cap34.11052wk Low--Dividend TTM35.66MShs Float133.230Historical High--Div YieldTTM1.75%Amplitude9.270Historical Low37.566Avg Price1Lot Size
Astrana Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 120.58%33.98M | -10.13%23.19M | -22.58%5.98M | -16.93%68.23M | -77.28%19.3M | 142.95%15.41M | 186.02%25.8M | -67.88%7.72M | 16.77%82.13M | 796.79%84.94M |
| Net income from continuing operations | -32.15%18.98M | 25.08%21.87M | 35.03%16.86M | 26.47%57.85M | 89.35%-94K | 17.06%27.97M | 55.02%17.48M | 9.07%12.49M | -0.68%45.74M | 96.08%-883K |
| Operating gains losses | -463.47%-3.75M | 72.76%-902K | 65.78%-632K | 37.42%-7.03M | -1,028.40%-2.9M | 135.29%1.03M | 34.06%-3.31M | 38.96%-1.85M | -125.33%-11.23M | 96.59%-257K |
| Depreciation and amortization | 68.73%7.26M | 75.12%7.44M | 18.73%5.1M | 1.17%17.75M | 20.65%4.9M | -9.46%4.31M | -2.34%4.25M | -1.87%4.29M | 0.15%17.54M | -7.91%4.06M |
| Deferred tax | -77.37%-337K | 99.73%-11K | -2,661.13%-7.25M | 12.84%-12.44M | 24.20%-8.51M | 97.04%-190K | -440.86%-4.03M | -87.01%283K | -286.13%-14.28M | -1,462.14%-11.22M |
| Other non cash items | 38.47%3.07M | -84.15%232K | 362.58%10.41M | 84.46%8.67M | -11.70%2.73M | 96.46%2.22M | 517.72%1.46M | 849.37%2.25M | 6.77%4.7M | -6.55%3.09M |
| Change In working capital | 107.49%2.03M | -315.71%-12.95M | -22.23%-23.16M | -1,096.32%-23.39M | -79.47%16.61M | 60.24%-27.05M | 159.87%6M | -295.78%-18.95M | 94.19%-1.96M | 402.54%80.91M |
| -Change in receivables | -118.39%-15.08M | -905.13%-19.78M | 14.62%-30.91M | 21.39%-20.26M | -76.40%20.39M | 82.83%-6.91M | 114.64%2.46M | 34.37%-36.2M | 4.51%-25.77M | 926.17%86.38M |
| -Change in prepaid assets | -418.72%-3.29M | 83.96%-284K | -740.91%-4.26M | -461.37%-2.96M | 29.05%-1.71M | 217.03%1.03M | -2,803.28%-1.77M | -112.13%-506K | -69.79%818K | -2.29%-2.41M |
| -Change in payables and accrued expense | -80.03%-1.08M | 1,797.73%24.29M | 126.65%961K | 80.23%-498K | 226.04%2.43M | 95.37%-601K | -87.46%1.28M | -629.96%-3.61M | -161.30%-2.52M | 108.15%745K |
| -Change in other current assets | -990.57%-1.73M | -67,800.00%-1.35M | 500.00%92K | 1,278.60%2.86M | 226.62%3.04M | 91.71%-159K | -99.86%2K | -100.86%-23K | 84.11%-243K | 20.27%-2.4M |
| -Change in other current liabilities | 301.97%10.15M | 334.35%11.78M | -123.87%-3.59M | -36.65%11.94M | 137.06%6.93M | 67.94%-5.02M | -136.18%-5.03M | -61.73%15.05M | 812.84%18.84M | -253.04%-18.71M |
| -Change in other working capital | ---- | -404.57%-27.6M | 129.62%14.54M | -309.30%-14.48M | ---- | ---- | 148.51%9.06M | 35.58%6.33M | 149.39%6.92M | --17.31M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 120.58%33.98M | -10.13%23.19M | -22.58%5.98M | -16.93%68.23M | -77.28%19.3M | 142.95%15.41M | 186.02%25.8M | -67.88%7.72M | 16.77%82.13M | 796.79%84.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 76.75%-8.11M | -1,441.17%-79.93M | -406.16%-71.04M | -821.17%-65.52M | -186.56%-11.43M | -331.30%-34.88M | -169.17%-5.19M | 28.85%-14.04M | -143.00%-7.11M | -66.22%13.2M |
| Net PPE purchase and sale | 44.09%-2.3M | -12.72%-2.84M | 97.52%-369K | -24.36%-28.53M | -696.50%-7.06M | -27.92%-4.11M | -85.55%-2.52M | 15.08%-14.85M | -19.34%-22.94M | 68.39%-886K |
| Net business purchase and sale | 152.38%3M | -21,188.86%-73.81M | -15,484.31%-50.65M | 59.16%-7.54M | 83.38%-1.84M | -17.87%-5.72M | 421.10%350K | 86.65%-325K | -372.65%-18.46M | -569.16%-11.06M |
| Net investment purchase and sale | -3,599.03%-3.81M | 16.35%-2.53M | 97.30%-27K | -118.98%-5.66M | -106.11%-1.54M | -145.24%-103K | -163.61%-3.02M | -4,661.90%-1M | -24.73%29.82M | -36.41%25.13M |
| Net other investing changes | 79.95%-5M | -37,600.00%-750K | -1,033.86%-19.99M | -685.12%-23.8M | -6,331.25%-997K | -118,876.19%-24.94M | -99.95%2K | 11,168.42%2.14M | 7,162.50%4.07M | 6.67%16K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 76.75%-8.11M | -1,441.17%-79.93M | -406.16%-71.04M | -821.17%-65.52M | -186.56%-11.43M | -331.30%-34.88M | -169.17%-5.19M | 28.85%-14.04M | -143.00%-7.11M | -66.22%13.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -525.49%-3.19M | 5,006.75%47.25M | 1,598.11%106.35M | 117.03%3.42M | 104.28%11.99M | 91.84%-510K | 95.24%-963K | -1,434.40%-7.1M | 57.94%-20.09M | 309.13%5.87M |
| Net issuance payments of debt | -322.46%-2.37M | 27,658.64%52.64M | 8,016.11%106.32M | 9,661.71%79.17M | 5,745.71%76.99M | 136.70%1.06M | -184.89%-191K | 147.64%1.31M | 98.57%-828K | 255.95%1.32M |
| Net common stock issuance | -378.00%-717K | --0 | --0 | -10.18%-10.19M | -226.38%-503K | 10.71%-150K | --0 | -4,047.39%-9.54M | -126.89%-9.25M | 39,700.00%398K |
| Cash dividends paid | 84.69%-218K | -149.45%-1.8M | 20.83%-95K | -342.44%-62.07M | -4,317.13%-59.81M | -1,086.67%-1.42M | 93.65%-722K | 89.81%-120K | 54.87%-14.03M | ---1.35M |
| Proceeds from stock option exercised by employees | --503K | --0 | --0 | -82.37%1.52M | -95.35%272K | --0 | --0 | -20.53%1.25M | -4.72%8.63M | 137.76%5.85M |
| Net other financing activities | ---391K | ---3.58M | --125K | -8.59%-5.01M | -1,361.95%-4.96M | --0 | ---- | ---- | -114.42%-4.61M | 75.72%-339K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -525.49%-3.19M | 5,006.75%47.25M | 1,598.11%106.35M | 117.03%3.42M | 104.28%11.99M | 91.84%-510K | 95.24%-963K | -1,434.40%-7.1M | 57.94%-20.09M | 309.13%5.87M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.77%325.96M | 22.15%335.44M | 2.13%294.15M | 23.57%288.03M | 49.06%274.29M | 25.63%294.27M | 15.41%274.61M | 23.57%288.03M | 20.17%233.1M | -10.13%184.02M |
| Current changes in cash | 213.53%22.68M | -148.26%-9.49M | 407.81%41.29M | -88.85%6.13M | -80.90%19.87M | 60.20%-19.98M | 628.45%19.65M | -376.86%-13.41M | 40.39%54.93M | 267.15%104.01M |
| End cash Position | 27.11%348.64M | 10.77%325.96M | 22.15%335.44M | 2.13%294.15M | 2.13%294.15M | 49.06%274.29M | 25.63%294.27M | 15.41%274.61M | 23.57%288.03M | 23.57%288.03M |
| Free cash flow | 180.41%31.69M | -12.60%20.35M | 178.64%5.61M | -32.93%39.7M | -85.43%12.24M | 128.92%11.3M | 203.80%23.29M | -208.89%-7.13M | 15.80%59.19M | 660.61%84.05M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.